Megaprosthesis versus Allograft Prosthesis Composite for massive skeletal defects

Area of Science:

• Orthopaedic Surgery
• Musculoskeletal Oncology
• Trauma Reconstruction

Background:

• Massive skeletal defects arise from tumors, failed joint replacements, fractures, trauma, and infection.
• Restoring bone length and function in these defects is a significant surgical challenge.
• Current reconstruction options include megaprostheses and allograft prosthesis composites (APCs).

Purpose of the Study:

• To review and compare the treatment outcomes, complications, and survival rates of megaprostheses and APCs.
• To analyze the efficacy of these reconstructive methods at various anatomical sites in the limbs.

Main Methods:

• Literature review of studies on megaprosthesis and allograft prosthesis composite reconstructions.
• Analysis of complications, functional outcomes, and survival data for both reconstructive techniques.
• Comparison of results across different anatomical locations (upper and lower limbs).

Main Results:

• Megaprostheses, while versatile, face issues with longevity and early complications like infection and fixation failure.
• Allograft prosthesis composites (APCs) offer biological fixation but introduce risks such as non-union and allograft resorption.
• Both methods have distinct complication profiles and survival rates that vary by patient selection and anatomical site.

Conclusions:

• Megaprostheses and APCs are viable options for massive skeletal defect reconstruction but have inherent limitations.
• Careful patient selection and understanding of the specific risks associated with each method are crucial for optimal outcomes.
• Further research is needed to improve the long-term durability and reduce complications in bone defect reconstruction.